These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

898 related articles for article (PubMed ID: 33600860)

  • 1. Progress of non-coding RNAs in triple-negative breast cancer.
    Liu J; Zhao G; Liu XL; Zhang G; Zhao SQ; Zhang SL; Luo LH; Yin DC; Zhang CY
    Life Sci; 2021 May; 272():119238. PubMed ID: 33600860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNAs: implications in targeted diagnoses, prognosis, and improved therapeutic strategies in human non- and triple-negative breast cancer.
    Rodríguez Bautista R; Ortega Gómez A; Hidalgo Miranda A; Zentella Dehesa A; Villarreal-Garza C; Ávila-Moreno F; Arrieta O
    Clin Epigenetics; 2018; 10():88. PubMed ID: 29983835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The functional significance and cross-talk of non-coding RNAs in triple negative and quadruple negative breast cancer.
    Paul U; Banerjee S
    Mol Biol Rep; 2022 Jul; 49(7):6899-6918. PubMed ID: 35235157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circular RNA-associated ceRNA network involved in HIF-1 signalling in triple-negative breast cancer: circ_0047303 as a potential key regulator.
    Darbeheshti F; Mahdiannasser M; Noroozi Z; Firoozi Z; Mansoori B; Daraei A; Bastami M; Nariman-Saleh-Fam Z; Valipour E; Mansoori Y
    J Cell Mol Med; 2021 Dec; 25(24):11322-11332. PubMed ID: 34791795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic characterization of non-coding RNAs in triple-negative breast cancer.
    Mei J; Hao L; Wang H; Xu R; Liu Y; Zhu Y; Liu C
    Cell Prolif; 2020 May; 53(5):e12801. PubMed ID: 32249490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The circRNA circIFI30 promotes progression of triple-negative breast cancer and correlates with prognosis.
    Xing L; Yang R; Wang X; Zheng X; Yang X; Zhang L; Jiang R; Ren G; Chen J
    Aging (Albany NY); 2020 Jun; 12(11):10983-11003. PubMed ID: 32497020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The circRNA circSEPT9 mediated by E2F1 and EIF4A3 facilitates the carcinogenesis and development of triple-negative breast cancer.
    Zheng X; Huang M; Xing L; Yang R; Wang X; Jiang R; Zhang L; Chen J
    Mol Cancer; 2020 Apr; 19(1):73. PubMed ID: 32264877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive transcriptome analysis identifies novel molecular subtypes and subtype-specific RNAs of triple-negative breast cancer.
    Liu YR; Jiang YZ; Xu XE; Yu KD; Jin X; Hu X; Zuo WJ; Hao S; Wu J; Liu GY; Di GH; Li DQ; He XH; Hu WG; Shao ZM
    Breast Cancer Res; 2016 Mar; 18(1):33. PubMed ID: 26975198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circular RNAs as novel biomarkers in triple-negative breast cancer: a systematic review.
    Foruzandeh Z; Dorabadi DG; Sadeghi F; Zeinali-Sehrig F; Zaefizadeh M; Rahmati Y; Alivand MR
    Mol Biol Rep; 2022 Oct; 49(10):9825-9840. PubMed ID: 35534586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of an mRNA-miRNA-lncRNA network prognostic for triple-negative breast cancer.
    Huang Y; Wang X; Zheng Y; Chen W; Zheng Y; Li G; Lou W; Wang X
    Aging (Albany NY); 2021 Jan; 13(1):1153-1175. PubMed ID: 33428596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. circUSP42 Is Downregulated in Triple-Negative Breast Cancer and Associated With Poor Prognosis.
    Yu J; Shen W; Xu J; Gong B; Gao B; Zhu J
    Technol Cancer Res Treat; 2020; 19():1533033820950827. PubMed ID: 32938310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-coding RNAs, another side of immune regulation during triple-negative breast cancer.
    Alghazali MW; Al-Hetty HRAK; Ali ZMM; Saleh MM; Suleiman AA; Jalil AT
    Pathol Res Pract; 2022 Nov; 239():154132. PubMed ID: 36183439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel long non-coding RNA linc-ZNF469-3 promotes lung metastasis through miR-574-5p-ZEB1 axis in triple negative breast cancer.
    Wang PS; Chou CH; Lin CH; Yao YC; Cheng HC; Li HY; Chuang YC; Yang CN; Ger LP; Chen YC; Lin FC; Shen TL; Hsiao M; Lu PJ
    Oncogene; 2018 Aug; 37(34):4662-4678. PubMed ID: 29755127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic regulation of triple negative breast cancer (TNBC) by TGF-β signaling.
    Vishnubalaji R; Alajez NM
    Sci Rep; 2021 Jul; 11(1):15410. PubMed ID: 34326372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA LINC00173 enhances triple-negative breast cancer progression by suppressing miR-490-3p expression.
    Fan H; Yuan J; Li X; Ma Y; Wang X; Xu B; Li X
    Biomed Pharmacother; 2020 May; 125():109987. PubMed ID: 32058222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CircPLK1 sponges miR-296-5p to facilitate triple-negative breast cancer progression.
    Kong Y; Yang L; Wei W; Lyu N; Zou Y; Gao G; Ou X; Xie X; Tang H
    Epigenomics; 2019 Aug; 11(10):1163-1176. PubMed ID: 31337246
    [No Abstract]   [Full Text] [Related]  

  • 17. Comprehensive analysis of novel three-long noncoding RNA signatures as a diagnostic and prognostic biomarkers of human triple-negative breast cancer.
    Fan CN; Ma L; Liu N
    J Cell Biochem; 2019 Mar; 120(3):3185-3196. PubMed ID: 30203490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Potential Long Non-Coding RNA Candidates that Contribute to Triple-Negative Breast Cancer in Humans through Computational Approach.
    Rahman MM; Hossain MT; Reza MS; Peng Y; Feng S; Wei Y
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulatory mechanisms, functions, and clinical significance of CircRNAs in triple-negative breast cancer.
    Lyu L; Zhang S; Deng Y; Wang M; Deng X; Yang S; Wu Y; Dai Z
    J Hematol Oncol; 2021 Mar; 14(1):41. PubMed ID: 33676555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA WEE2-AS1 promotes proliferation and inhibits apoptosis in triple negative breast cancer cells via regulating miR-32-5p/TOB1 axis.
    Wang R; Huang Z; Qian C; Wang M; Zheng Y; Jiang R; Yu C
    Biochem Biophys Res Commun; 2020 Jun; 526(4):1005-1012. PubMed ID: 32307083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.